CRT 2026

Panel Discussion | Stroke and Carotid Intervention

Moderator(s)

• 

  J. Michael Bacharach, MD

  Section Head, Vascular Medicine and Peripheral Vascular Intervention
  North Central Heart Institute
  Sioux Falls, South Dakota, United States

  Disclosure(s): No financial relationships to disclose
• 

  James Stephen Jenkins, MD

  Section Head, Interventional Cardiology Director, Interventional Cardiology Research
  Ochsner Medical Center
  New Orleans, Louisiana, United States

  Disclosure information not submitted.
• 

  James P. Zidar, MD, FSCAI

  Clinical Professor of Medicine
  University of North Carolina/Rex Healthcare
  Raleigh, North Carolina, United States

  Disclosure(s): Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

• 

  Steve D. Abramowitz, MD

  Chair, Vascular Surgery
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  Herbert D. Aronow, MD, MPH

  Medical Director, Heart & Vascular Services
  Henry Ford Health
  Detroit, Michigan, United States

  Disclosure information not submitted.
• 

  Ryan D. Madder, MD

  Program Director, Interventional Cardiology Fellowship
  Corewell Health East/William Beaumont University Hospital
  Northville, Michigan, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus Vascular Robotics: Consulting Fees (e.g., advisory boards) (Terminated), Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Orchestra Biomed: Consulting Fees (e.g., advisory boards) (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Gary Roubin, MD PhD

  Chair
  CREST2 Trial Interventional Management Committee
  Jackson, Wyoming, United States

  Disclosure(s): Cardiomech Inc: Stock-privately held company (Ongoing); Contego Medical Inc: Stock Options [in privately held companies] (Ongoing); Excision Medical Inc: Stock-privately held company (Ongoing); Inspire MD Inc: Stock-publicly held company (excluding mutual/index funds) (Ongoing)
• 

  Horst Sievert, MD, FSCAI, FACC, FESC

  Director
  CardioVascular Center Frankfurt CVC
  Frankfurt, Hessen, Germany

  Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)
• 

  Peter A. Soukas, MD, FSCAI

  Director, Vascular Medicine & Interventional PV Lab
  Brown University Health Cardiovascular Institute/ Brown Medical School
  Providence, Rhode Island, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Endologix, Contego Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Grant/Research Support (Ongoing)
• 

  Michael C. Stoner, MD

  Chief, Division of Vascular Surgery
  University of Rochester
  Rochester, New York, United States

  Disclosure(s): No financial relationships to disclose